PGK1 is the first ATP-producing enzyme in glycolysis; therefore, it plays a key role in cellular redox balance, and was recently proposed as a molecular target for antiglycolytic therapy of ovarian cancer [35]. The gene discussed is PGK1; the disease is ovarian carcinoma.